Resistance of human primary mesenchymal stem cells to cytotoxic effects of nutlin-3 in vitro

被引:0
|
作者
Bajelan, Babak [1 ]
Zaki-Dizaji, Majid [2 ]
Rahmani, Babak [1 ]
Darzi, Sina [3 ]
Darabi, Shahram [1 ]
Rajaei, Farzad [1 ]
机构
[1] Qazvin Univ Med Sci, Cellular & Mol Res Ctr, Qazvin, Iran
[2] Univ Tehran Med Sci, Sch Med, Dept Med Genet, Tehran, Iran
[3] Shahrekord Univ Med Sci, Sch Adv Technol, Dept Mol Med, Shahrekord, Iran
关键词
bone marrow; human; MSCs; nutlin-3; TP53; PROTEIN-PROTEIN INTERACTION; SMALL-MOLECULE INHIBITORS; MDM2; ANTAGONISTS; CANCER-CELLS; P53; PATHWAY; PHARMACOLOGICAL ACTIVATION; THERAPEUTIC STRATEGY; CARCINOMA CELLS; UP-REGULATION; BONE-MARROW;
D O I
10.1002/jcb.29324
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background The small-molecule nutlin-3 was found to be an effective therapeutic compound and p53 activator, and acts as a murine double minute 2 antagonist, although these findings need to be clinically confirmed. The essential components of the bone marrow include mesenchymal stem cells (MSCs), which play a key role in protecting, regenerating, and proliferating hematopoietic stem cells (HSCs). This feature is vital for HSC after exposure to myelotoxic anticancer agents; nevertheless, the effects of nutlin-3 on MSCs remain to be disclosed. The present research study was conducted to examine the antiproliferative and proapoptotic effectiveness of nutlin-3 in bone marrow MSCs (BMSCs). Materials and Methods Human-derived BMSCs were cultured for different durations, that is, 24, 48, and 72 hours, and treated using various concentrations of nutlin-3, including 5, 10, 25, 50, and 100 mu M. To investigate the effect of nutlin-3 on the apoptosis, cell vitality and proliferation in BMSCs, the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), thiazolyl blue tetrazolium bromide, propidium iodide (PI) and annexin V assay, as well as real-time polymerase chain reaction, were used. Results BMSCs viability significantly decreased (P < .05) in the cells treated at concentrations of 50 and 100 mu M for 24 hours and concentrations of 25, 50, and 100 mu M for 48 hours and at all concentrations for 72 hours. The apoptosis of BMSCs (TUNEL positive) was significantly more visible at concentrations of 25 and 50 mu M compared with that in the controls (P < .05), while this increased through dose-dependent processes. Annexin V/PI staining revealed negligible dose-dependent increases in all the apoptotic cells after 72 hours of incubation, and this apoptosis elevation was significant at 25 and 50 mu M (P < .05). Conclusion Resistance to nutlin-3 was observed in human bone marrow-derived MSCs; nevertheless, further clinical data are required to be obtained with long-duration exposure to confirm the present findings.
引用
收藏
页码:788 / 796
页数:9
相关论文
共 50 条
  • [1] The effects of Nutlin-3 on morphology, cellular proliferation, and apoptosis in rat primary mesenchymal stem cells
    Bajelan, Babak
    Zaki-Dizaji, Majid
    Darabi, Shahram
    Rajaei, Farzad
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) : 11424 - 11430
  • [2] Cytotoxic effects of acrylonitrile on human umbilical cord mesenchymal stem cells in vitro
    Sun, Xiaochun
    Sun, Min
    Xie, Yan
    Zhai, Wei
    Zhu, Wei
    Ma, Rui
    Lu, Rongzhu
    Xu, Wenrong
    [J]. MOLECULAR MEDICINE REPORTS, 2014, 9 (01) : 97 - 102
  • [3] Human mesenchymal stem cells are resistant to cytotoxic and genotoxic effects of cisplatin in vitro
    Bellagamba, Bruno Correa
    Ribas de Abreu, Bianca Regina
    Grivicich, Ivana
    Markarian, Carolina Franke
    Chem, Eduardo
    Camassola, Melissa
    Nardi, Nance Beyer
    Dihl, Rafael Rodrigues
    [J]. GENETICS AND MOLECULAR BIOLOGY, 2016, 39 (01) : 129 - 134
  • [4] In vitro cytotoxic and pharmacological effects of rapamycin on human chondrocytes, synoviocytes, and bone mesenchymal stem cells
    Pape, E.
    Pinzano, A.
    Henrionnet, C.
    Scala-Bertola, J.
    Gillet, P.
    Gambier, N.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 120 - 120
  • [5] The Cytotoxic Effects of Human Mesenchymal Stem Cells Induced by Uranium
    Quan, Yi
    Yu, Xiaofang
    [J]. BIOLOGY-BASEL, 2024, 13 (07):
  • [6] Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells
    Endo, Shinji
    Yamato, Kenji
    Hirai, Sachiko
    Moriwaki, Toshikazu
    Fukuda, Kuniaki
    Suzuki, Hideo
    Abei, Masato
    Nakagawa, Ichiro
    Hyodo, Ichinosuke
    [J]. CANCER SCIENCE, 2011, 102 (03) : 605 - 613
  • [7] Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells
    Tisato, Veronica
    Norcio, Alessia
    Celeghini, Claudio
    Milani, Daniela
    Gonelli, Arianna
    Secchiero, Paola
    [J]. CLINICS, 2014, 69 (01) : 68 - 74
  • [8] Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma
    Belletti, D.
    Tosi, G.
    Riva, G.
    Lagreca, I.
    Galliania, M.
    Luppi, M.
    Vandelli, M. A.
    Forni, F.
    Ruozi, B.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 490 (1-2) : 85 - 93
  • [9] Nutlin-3 reverses the epithelial-mesenchymal transition in gemcitabine-resistant hepatocellular carcinoma cells
    Wu, Qiong
    Wang, Xi
    Liu, Jing
    Zheng, Jiyue
    Liu, Yang
    Li, Yumei
    Su, Fang
    Ou, Weili
    Wang, Rui
    [J]. ONCOLOGY REPORTS, 2016, 36 (03) : 1325 - 1332
  • [10] Analysis of the MDM2 antagonist nutlin-3 in human prostate cancer cells
    Logan, Ian R.
    McNeill, Hesta V.
    Cook, Susan
    Lu, Xiaohong
    Lunec, John
    Robson, Craig N.
    [J]. PROSTATE, 2007, 67 (08): : 900 - 906